Brief: Reshape Lifesciences Says License Agreement Provides $200,000 In Upfront Payments
Sept 21 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES® SIGNS EXCLUSIVE LICENSE AGREEMENT
WITH
BIORAD MEDISYS FOR OBALON® GASTRIC BALLOON SYSTEM
* RESHAPE LIFESCIENCES INC - LICENSE AGREEMENT PROVIDES
$200,000
IN UPFRONT PAYMENTS
Source text for Eikon: ID:nGNX1nb6B1
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity